Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release

BACKGROUND: Human glypican-3 (hGPC3) is a protein highly expressed in hepatocellular carcinoma (HCC) but limited in normal tissues, making it an ideal target for immunotherapy. The adoptive transfer of hGPC3-specific chimeric antigen receptor T (CAR-T) cells for HCC treatment has been conducted in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuan, Wen, Jianyun, Yi, Honglei, Hou, Xiaorui, Yin, Yue, Ye, Guofu, Wu, Xuedong, Jiang, Xiaotao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Early diagnosis and therapeutic advances for liver cancer: from bench to bedside
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065297/
https://www.ncbi.nlm.nih.gov/pubmed/32215059
http://dx.doi.org/10.1177/1758835920910347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065297/
https://www.ncbi.nlm.nih.gov/pubmed/32215059
http://dx.doi.org/10.1177/1758835920910347

Ejemplares similares